GTLB INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that GitLab Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
September 25, 2024 16:04 ET
|
Robbins Geller Rudman & Dowd LLP
SAN DIEGO, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of GitLab Inc. (NASDAQ: GTLB) securities between June 6, 2023 and March 4,...
Diamondback Energy, Inc. Schedules Third Quarter 2024 Conference Call for November 5, 2024
September 25, 2024 16:01 ET
|
Diamondback Energy, Inc.
MIDLAND, Texas, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Diamondback Energy, Inc. (NASDAQ: FANG) (“Diamondback”), today announced that it plans to release third quarter 2024 financial results on November...
Armada Hoffler Announces Commencement of Public Offering of Common Stock
September 25, 2024 16:01 ET
|
Armada Hoffler Properties, Inc.
VIRGINIA BEACH, Va., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Armada Hoffler (NYSE: AHH) today announced that it has commenced an underwritten public offering of 7,000,000 shares of its common stock. The...
Viper Energy, Inc., a Subsidiary of Diamondback Energy, Inc., Schedules Third Quarter 2024 Conference Call for November 5, 2024
September 25, 2024 16:01 ET
|
Viper Energy, Inc.
MIDLAND, Texas, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Viper Energy, Inc. (NASDAQ: VNOM) (“Viper”), a subsidiary of Diamondback Energy, Inc. (NASDAQ: FANG) (“Diamondback”), today announced that it plans...
NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in the United States
September 25, 2024 16:01 ET
|
NuCana plc
EDINBURGH, United Kingdom, Sept. 25, 2024 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced the issuance of a new patent by the United States Patent and Trademark Office (USPTO) covering...
Abivax Provides Update on Ulcerative Colitis (UC) Combination Therapy Program Strategy and Announces Early Preclinical Combination Data of Obefazimod and Etrasimod in Inflammatory Bowel Disease (IBD) Mouse Model
September 25, 2024 16:01 ET
|
Abivax
Abivax Provides Update on Ulcerative Colitis (UC) Combination Therapy Program Strategy and Announces Early Preclinical Combination Data of Obefazimod and Etrasimod in Inflammatory Bowel Disease...
ImPact Biotech to Present at Oppenheimer Private Life Sciences Company Showcase
September 25, 2024 16:01 ET
|
ImPact Biotech
TEL AVIV, Israel, Sept. 25, 2024 (GLOBE NEWSWIRE) -- ImPact Biotech, a clinical-stage biotechnology company focused on developing Padeliporfin vascular targeted photodynamic (VTP) therapy to treat a...
AVNW INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Aviat Networks, Inc. and Encourages Investors to Contact the Firm!
September 25, 2024 16:00 ET
|
Bronstein, Gewirtz & Grossman, LLC
NEW YORK, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Aviat Networks, Inc. (“Aviat”...
GGR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Gogoro Inc. and Encourages Investors to Contact the Firm!
September 25, 2024 16:00 ET
|
Bronstein, Gewirtz & Grossman, LLC
NEW YORK, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Gogoro Inc. (“Gogoro” or “the...
MEI INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Methode Electronics, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
September 25, 2024 16:00 ET
|
Bronstein, Gewirtz & Grossman, LLC
NEW YORK, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been...